Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)
Jaime E. C. Hallak(Conselho Nacional de Desenvolvimento Científico e Tecnológico), Antônio Waldo Zuardi(Universidade de São Paulo), José Alexandre S. Crippa(Universidade de São Paulo), João Paulo Machado‐de‐Sousa(Conselho Nacional de Desenvolvimento Científico e Tecnológico), Rafael Faria Sanches(Universidade de Ribeirão Preto), Sandra Aparecida Bernardo(Universidade de São Paulo), Simone Cecílio Hallak Regalo(Conselho Nacional de Desenvolvimento Científico e Tecnológico), Cristiano Chaves(Queen's University), Clarissa Trzesniak(Conselho Nacional de Desenvolvimento Científico e Tecnológico)
Cited by 122
Related Papers
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
|Psychological Medicine|2018|819
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
|Neuropsychopharmacology|2011|763
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
|Journal of Psychopharmacology|2010|530
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
|Brazilian Journal of Psychiatry|2015|484
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression
|Journal of Clinical Psychopharmacology|2015|465